lobbying_activities: 2819800
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2819800 | 6702f07a-360d-4b9a-85ff-00afa5e530c4 | Q2 | MARSHALL & POPP, LLC | 401105121 | GENENTECH, INC. | 2022 | second_quarter | CPT | Issues related to intellectual property and patent reform, including S.1435, the Affordable Prescriptions for Patients Act and H.R.4521/S.1260, the United States Innovation and Competition Act. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2022-07-15T00:51:16-04:00 |